Last reviewed · How we verify
NCT04525443
Endothelial Function and COVID-19
trial in COVID-19 in 110 participants. Completed in 11 February 2021.
11 November 2020
Quick facts
| Lead sponsor | Hospital San Carlos, Madrid |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 3 June 2020 |
| Primary completion | 11 November 2020 |
| Estimated completion | 11 February 2021 |
| Sites | 2 locations across United States, Spain |
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
Hospital San Carlos, Madrid
Who can join
Eligibility, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study aims to investigate the endothelial vasodilator function in patients with COVID-19
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.
Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al · · 2021 · cited 102× · PMID 33992686 · DOI 10.1016/j.jinf.2021.05.004 -
In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19.
Mejia-Renteria H, Travieso A, Sagir A, Martínez-Gómez E, et al · · 2021 · cited 42× · PMID 34706286 · DOI 10.1016/j.ijcard.2021.10.140 -
Endothelial dysfunction in COVID-19: A potential predictor of long-COVID?
Seitz A, Ong P. · · 2022 · cited 16× · PMID 34838682 · DOI 10.1016/j.ijcard.2021.11.051
Verify or expand the search:
- PubMed search for NCT04525443
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Hospital San Carlos, Madrid trials
Trials by the same sponsor.
- NCT06310941 — Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection · NA · not yet recruiting
- NCT07002658 — Clinical Impact of Surgical Wound Morbidity According to the Type of Saphenous Vein Harvesting Technique (Endoscopic vs. · NA · not yet recruiting
- NCT06113939 — Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning · NA · not yet recruiting
- NCT06156059 — Oral Bedtime Melatonin in Critically Ill Patients · Phase 4 · unknown
- NCT07390175 — Ablation of Human Cardiac Fibrillation Based on Models of Hierarchical Organization of Tissue Excitation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04525443 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital San Carlos, Madrid
- Last refreshed: 26 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04525443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing